In decision support for imaging studies, who calls the shots?
Longer-term readers of this column may recall that I have slowly but surely been working my way backwards through stacks of journals which have accumulated on tables, shelves, and various other horizontal surfaces of my home over the years. New issues get priority, as their contents are more likely to be relevant to current practice, but an item from early 2012 just caught my attention.
The piece examined the impact of putting “clinical decision support” into a computerized order-entry system, specifically for the researchers’ ER in the setting of ordering pulmonary CTAs. I won’t get into the details, but they reported an over 20% decrease in usage and almost 70% increase in diagnostic yield of their CTAs over a two-year period.
Sounds impressive, right? Does anybody who actually reads these studies think they aren’t over-ordered? In the past 10–15 years, I’ve seen them go from a very small minority of the daily CT load to one of the most common studies gracing my worklist. It’s now a rare exception that I get a chest which isn’t a CTA.
It’s not hard to imagine why. Thrombosis in the pulmonary arteries is nothing to take lightly, and isn’t exactly a rare bird. It can present in more than a couple of ways, and can even be an incidental finding. It’s not uncommon for health care professionals, let alone med students, to be taught that if you even think of PE in a given situation, you should probably rule it out.
All of which makes it a dicey matter to try spelling out, in one-size-fits-all, cookie-cutter fashion, circumstances under which a physician should not order a CTA. Some other denizens of the health care sphere who have gained the ability to order scans may be comfortable blindly using checklists and guidelines. However, a doc with four years of med school and another three or more years of postgraduate training, plus however many subsequent years of practice, is going to be very mindful of how protean disease (let alone PE) can be, and resistant if not outraged when someone who hasn’t even seen his patients tries telling him how he should be managing them…especially when the liability of a bad outcome is his, not the protocol writer’s.
I, myself, have not seen many of these “decision support” systems in action. I do not know whether they most commonly take the form of gentle suggestions and reminders to clinicians, or more forceful directives. I would not be surprised if in some facilities this “support” winds up meaning that a clinician, in order to get the test he reasonably believes his patient needs, must enter false or misleading information to get the computer-based order entry system to comply. Or more insidious coercion, wherein a physician doing what he feels is right for his patients runs the risk of administrative or financial punishment for not meeting metrics…perhaps even those established at a state or federal level in the name of “quality.”[[{"type":"media","view_mode":"media_crop","fid":"30444","attributes":{"alt":"Eric Postal, MD","class":"media-image media-image-right","id":"media_crop_9559956955712","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3197","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"Eric Postal, MD","typeof":"foaf:Image"}}]]
The term “decision support” implies that the decision-maker is still calling the shots, and that the support mechanism is there to help, rather than hinder or usurp, the decision-making process. Hopefully, if such support systems become more widely adopted and/or required, this won’t ultimately turn out to be another instance of friendly-sounding verbiage covering up an uglier truth.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.